Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors

Aura Herrera Martinez; R van den Dungen; Fadime Dogan - Oruç; Peter van Koetsveld; MD Culler; W.W. de Herder; RM Luque; R.A. Feelders; Leo Hofland

doi:10.1530/erc-19-0086

Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors

Aura Herrera Martinez, R van den Dungen, Fadime Dogan - Oruç, Peter van Koetsveld, MD Culler, W.W. de Herder, RM Luque, R.A. Feelders, Leo Hofland

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	585-599
Number of pages	15
Journal	Endocrine-Related Cancer
Volume	26
Issue number	6
DOIs	https://doi.org/10.1530/erc-19-0086
Publication status	Published - 2019

Research programs

EMC MM-01-39-01

Access to Document

10.1530/erc-19-0086

http://hdl.handle.net/1765/116858

Cite this

@article{04c74769cd2e4ae7806d7e8bf808375b,

title = "Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors",

author = "{Herrera Martinez}, Aura and {van den Dungen}, R and {Dogan - Oru{\c c}}, Fadime and {van Koetsveld}, Peter and MD Culler and {de Herder}, W.W. and RM Luque and R.A. Feelders and Leo Hofland",

year = "2019",

doi = "10.1530/erc-19-0086",

language = "Undefined/Unknown",

volume = "26",

pages = "585--599",

journal = "Endocrine-Related Cancer",

issn = "1351-0088",

publisher = "Bioscientifica Ltd",

number = "6",

}

TY - JOUR

T1 - Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors

AU - Herrera Martinez, Aura

AU - van den Dungen, R

AU - Dogan - Oruç, Fadime

AU - van Koetsveld, Peter

AU - Culler, MD

AU - de Herder, W.W.

AU - Luque, RM

AU - Feelders, R.A.

AU - Hofland, Leo

PY - 2019

Y1 - 2019

U2 - 10.1530/erc-19-0086

DO - 10.1530/erc-19-0086

M3 - Article

SN - 1351-0088

VL - 26

SP - 585

EP - 599

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

IS - 6

ER -